OraSure Technologies Inc of Bethlehem has a new president and CEO.
The company announced this week that Carrie Eglinton Manner has been appointed to the post effective June 4.
Eglinton Manner will also join the OraSure board of directors.
She succeeds Nancy Gagliano, who was appointed interim CEO in March 2022. Dr. Gagliano will remain on the OraSure Board. Gagliano took over when former CEO Stephen Tang left the post.
The company said Eglinton Manner brings more than 25 years of healthcare leadership and transformation expertise to OraSure. She is currently senior vice president of Advanced & General Diagnostics Clinical Solutions, at Quest Diagnostics.
Under her leadership, Quest’s Advanced Diagnostics, a portfolio with over $2 billion in revenue, accelerated its growth rate with strong profitability. She has responsibility for bringing innovative diagnostic solutions to market in the areas of women’s health, neurology, oncology, cardiovascular, metabolic, endocrinology, infectious disease and immunology testing services, as well as drug monitoring and toxicology.
Additionally, she leads Quest’s pharmaceutical services, AmeriPath/Dermpath and international businesses. She led Quest’s molecular genetics team in pioneering next-generation sequencing innovation which reduced cost and increased access for patients to precision health insights.
Prior to Quest Diagnostics, she served for 20 years in a variety of leadership roles of increasing responsibility including multiple, distinct business units with global engineering and manufacturing responsibilities at GE Healthcare, a division of General Electric (GE). A champion for inclusion and diversity, Eglinton Manner served as co-chair for Quest’s African American Employee Business Network, and prior to that, GE’s Women’s Network.
“Carrie has a proven track record of transformative leadership, disciplined operational execution, and driving innovation at two industry-leading healthcare companies,” said Michael Celano, chairman of the board of OraSure. “Importantly, Carrie is a results-oriented executive who brings first-hand strategic insights on the testing industry and services businesses. The board is confident that Carrie’s experience and skillset make her ideally suited to lead OraSure as we continue to scale up manufacturing for InteliSwab and drive growth across all of our platforms.”
Eglinton Manner’s appointment as CEO comes in tandem with a decision by the OraSure board to conclude its previously announced review of strategic alternatives and for the company to move forward under her leadership. Market conditions and the board’s belief in the company’s ability to further build upon recent operational successes with Carrie’s leadership were factors in the decision.
Celano continued, “After completing a thorough review of strategic alternatives with the assistance of independent financial and legal advisors, the board believes the best path to create value is with improved execution and a renewed focus on driving profitable growth as a market leader in the areas of simple, reliable, point-of-care and home tests as well as innovative and easy-to-use sample collection technologies. We are excited to begin this next chapter in our company’s journey and want to thank our executive leadership team and all of our colleagues for their continued focus and dedication to our products and serving the needs of our customers around the world.”